Cyclopharm Limited has released a press release.
Technegas Approved in Russia
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Cyclopharm
- USFDA Grants Cyclopharm USD$2.9m Application Fee Waiver
- Cyclopharm Lodges NDA for Technegas with the USFDA
- Cyclopharm Company Update
- CYC Institutional Placement - Premium To Share Price
- Agreement to utilise cyclotron facility assets
Later from Cyclopharm
- USFDA Approval to File Received for Technegas
- CYC 1H2020 Business Update
- Technegas USA Trial Successfully Meets Primary Endpoint
- Cyclopharm Investor Presentation
- USFDA Approval Progress for Technegas and Business Update
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm